Actively Recruiting
ENDO1000 - A UK-wide Endometriosis Research Project
Led by University of Edinburgh · Updated on 2026-01-09
1000
Participants Needed
1
Research Sites
264 weeks
Total Duration
On this page
Sponsors
U
University of Edinburgh
Lead Sponsor
C
Clinical Hospital Centre Zagreb
Collaborating Sponsor
AI-Summary
What this Trial Is About
Approximately 1.5 million people in the UK, and 200 million globally live with endometriosis, and it is estimated to affect 1 in 10 women of reproductive age. Endometriosis is a chronic pain condition where the lining of the uterus (endometrium) grows in areas outside the uterus. This can cause patients a range of symptoms including severe pain, fatigue, irregular periods, infertility and gastrointestinal symptoms. There is a clear unmet need for early diagnosis and more effective pain management for people who suffer from endometriosis. Endometriosis is a heterogeneous disease in terms of symptoms, trajectory, and indicated therapeutic course, which highlights the need to develop personalised/targeted approaches for effective longitudinal management which are acceptable and accessible to patients and their health care team. The goal of this study is to accelerate discovery and advance data-driven research into endometriosis diagnosis and treatment by collecting large, multimodal, longitudinal data. To achieve this goal, the investigators plan to deliver a longitudinal cohort study. Approximately 3000 UK individuals with endometriosis will be invited over a 24-month period to self-report symptoms that include, pain, menstrual cycle, painkiller use, sleep, exercise, diet and bowel habits via a bespoke ENDO1000 mobile app. A cohort of 1000 women will be asked to complete more in-depth questionnaires asking about endometriosis history, quality of life and treatments. This cohort of women will be asked to take self-collected biological samples (blood, urine, saliva, vaginal swab and faeces). The investigators will look at, for example, inflammatory markers, examine the microbiome and may look at DNA, with permission to see if there are any markers that can help with diagnosis or treatment of endometriosis. At the same time participants will be asked to wear a smartwatch which will monitor, for example, temperature, ambient light, sleep patterns and movement. All this will help the investigators to build a picture over time of the participant's endometriosis symptoms, treatments and what may cause symptoms to flare which in turn could lead to more patient led treatments.
CONDITIONS
Official Title
ENDO1000 - A UK-wide Endometriosis Research Project
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 16 or over
- Have received a clinical diagnosis of endometriosis (based on MRI, ultrasound, or laparoscopy) within the last 10 years
- Living within the UK
- Willing and able to use the ENDO1000 mobile app or web-based equivalent
You will not qualify if you...
- Currently pregnant
- Known severe blood clotting disorder
- Known active Hepatitis B, Hepatitis C, or HIV infection (due to restrictions on sample postage)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Edinburgh
Edinburgh, United Kingdom
Actively Recruiting
Research Team
A
Ann M Doust, DipN
CONTACT
P
Priscilla Fernandez, BSc, BM
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here